Metagenomics Market: Global Market Analysis with Forecasts by Application, Technology, Product and User with Executive and Consultant Guides 2025 to 2029
Metagenomics Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Metagenomics, the process of identifying various genomes from a single sample, has a long history of use, particularly in detecting known life forms in water and soil samples. However, significant shifts are occurring due to advancements in Next Generation Sequencing technology and the continuous decrease in sequencing costs. These developments have revolutionized the field, enabling the identification of numerous unknown life forms and additional genetic material, such as tumor DNA, from a single source.
This latest report delves into the Metagenomics market from 2025 to 2029, offering valuable insights including:
- Overview of the Metagenomics market structure
- Analysis of healthcare spending
- Examination of market trends
- Identification of factors propelling growth
- Exploration of factors hindering growth
- Recent advancements in metagenomics
- Profiles of key companies in the Metagenomics sector
The report presents global market forecasts for Metagenomics across various segments:
- Countries: USA, Canada, Germany, France, UK, rest of Europe, Japan, China, South Korea, rest of APAC, Brazil, Mexico, rest of LATAM, Middle East and Africa, Global
- Applications: Clinical, Microbiome, Agriculture, Industrial and Other
- Technologies: 16srRNA, Shotgun, WGS, Other
- Users: Pharmaceutical, Clinical, Academic, Other
- Products: Instruments, Software, Reagents and Kits, Services
This comprehensive analysis offers a detailed outlook on the Metagenomics market landscape, providing essential information for stakeholders across different sectors.
Delve into this in-depth research report to grasp the transformative influence of metagenomic assays in shaping the future of medical treatment. Gain insights into the technology's intricacies, navigate through its complexities, and explore the myriad possibilities that await.
Our research empowers you to become the go-to expert within your organization for navigating these transformative developments.
This latest report delves into the Metagenomics market from 2025 to 2029, offering valuable insights such as:
- Overview of the Metagenomics market structure
- Analysis of healthcare spending
- Examination of market trends
- Identification of factors propelling growth
- Exploration of factors hindering growth
- Recent advancements in metagenomics
- Profiles of key companies in the Metagenomics sector
The report presents global market forecasts for Metagenomics across various segments:
- Countries: USA, Canada, Germany, France, UK, rest of Europe, Japan, China, South Korea, rest of APAC, Brazil, Mexico, rest of LATAM, Middle East and Africa, Global
- Applications: Clinical, Microbiome, Agriculture, Industrial, and Other
- Technologies: 16srRNA, Shotgun, WGS, Other
- Users: Pharmaceutical, Clinical, Academic, Other
- Products: Instruments, Software, Reagents and Kits, Services
This comprehensive analysis offers a detailed outlook on the Metagenomics market landscape, providing essential information for stakeholders across different sectors.
Pricing options
- $6,995: single-user (encrypted file - one user/device)
- $10,495: multi-user (encrypted file - up to 5 users/devices)
- $13,995: company (unencrypted file)
Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin3 PDF Reader will be provided at report delivery.
Company license files are not encrypted and can be accessed using a PDF Reader.
A full explanation of license type definitions can be found here.
Price promise
We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.
Latest report
If an update is published within 30 days of your purchase, you will receive it free of charge.
Serious Security
We take your data and security seriously. See our privacy policy for details of how we manage your data.
Sales Support
If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.
- Total Trust
Current Partnering is part of Biopharma Research Ltd based in York, United Kingdom. We have been trading successfully online since 2012 and work with some of the most famous brands in the business. We carefully select our partners to ensure that publications meet the expectations of our demanding customers.
Arc Bio
BaseClear
BGI Genomics Co. Ltd
Biome Makers
bioMérieux Diagnostics
Bio-Rad Laboratories
CosmosID
Element Biosciences
Fusion Genomics
Helix OpCo
Illumina
Institute for Metagenomics
Karius
Metabiomics Corp
Metagenomi
MetaSUB International Consortium
Microbiome Insights
MicroGenDx
Molecular Stethoscope
Norgen Biotek Corp
Noscendo
Novogene Bioinformatics Technology Co
One Codex
OraSure Technologies
Oxford Nanopore Technologies
Pacific Biosciences
PathoQuest
PerkinElmer
Promega
QIAGEN
Second Genome
Siemens Healthineers
Sysmex
Takara Bio
Ultima Genomics
Zymo Research Corp
Methodology
This report is based on research conducted over the last four months. Data is derived primarily from executive comments, quarterly reports, and industry association data. While much information is kept confidential by suppliers this report infers revenues based on estimates of individual company activities by channel historically, currently, and as intermittently reported. This report aggregates supplier revenues and compares these to industry and other sources to arrive at estimates of current and historical market size. Forecasts are firstly based on historical growth rates and the current overall economic growth outlook for specific regions and countries. Secondarily the growth outlook is modified to account for factors specific to the market under study as
explained in the Situation Analysis.
Sources
Sources of information include the World Health Organization, the International Monetary Fund, the World Bank, several U.S. and European Union government bodies and industry associations. Considerable primary information is collected from company annual and quarterly reports, industry associations, industry participants and executives, whose information and insight are regularly solicited. Much company information comes from company websites, investor presentations, press releases, annual reports, 10K filings, news reports, national statistical services and industry blogs. Technical information is primarily based on published academic literature.
Author
The principal author of this report holds a M.B.A. in Finance and Strategy from the University of British Columbia. He also holds a B.Sc. in Chemistry
from the same university. He is a graduate of the Harvard Business School program Finance for Senior Executives. He is a graduate of The Burke Institute Seminar in Market Research. He has worked in clinical laboratory research and testing in a hands-on capacity. He is a co-author of the paper The Radioimmunoassay of Angiotensinogen II by Antibody Trapping. He has considerable experience in mergers, acquisitions, and business development.
